Shopping Cart
Remove All
Your shopping cart is currently empty
LT-630 is an inhibitor of HDAC6. It alleviates liver damage by reducing oxidative stress injury.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | LT-630 is an inhibitor of HDAC6. It alleviates liver damage by reducing oxidative stress injury. |
| In vitro | LT-630 (2-8 nM, 3 hours and 24 hours) effectively inhibits acetaminophen-induced cell damage, mitigating increased oxidative stress and apoptosis in AML-12 cells. |
| In vivo | Prior to APAP administration, LT-630 (10-40 mg/kg, intravenous injection) effectively reduces oxidative stress and hepatocyte apoptosis induced by acetaminophen (APAP) in mice by eliminating ROS. |
| Formula | C19H17FN4O3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.